Best VCs for Diagnostics
145 venture capitalists actively investing in Diagnostics.
Partner
Khosla Ventures
Alex invests where computation, biology, and healthcare converge. His scientific and clinical background supports a systems view of biomarker discovery, therapeutics, diagnostics, personalized medicin
Venture Partner
Hadean Ventures
Reinhard Krickl invests or supports investment decisions through Hadean Ventures's published strategy: Back science-driven European healthcare companies with the potential to improve patient outcomes
Senior Advisor
Hadean Ventures
Florian Eckhardt is listed in a Senior Advisor capacity at Hadean Ventures. The profile preserves that non-investment or undisclosed-role distinction and uses the firm's mandate only as shared context
Venture Partner
Hadean Ventures
Nora Kaarela invests or supports investment decisions through Hadean Ventures's published strategy: Back science-driven European healthcare companies with the potential to improve patient outcomes and
Partner, Diagnostics
Kurma Partners
The official roster identifies Benjamin Belot as Partner, Diagnostics. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrower
Managing Partner, Biofund
Kurma Partners
The official roster identifies Rémi Droller as Managing Partner, Biofund. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrow
Partner, Biofund
Kurma Partners
The official roster identifies Amanda Gett as Partner, Biofund. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrower individ
Partner, Diagnostics
Kurma Partners
The official roster identifies Alain Horvais as Partner, Diagnostics. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrower i
Managing Partner, Biofund
Kurma Partners
The official roster identifies Thierry Laugel as Managing Partner, Biofund. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narr
Partner Germany, Biofund
Kurma Partners
The official roster identifies Peter Neubeck as Partner Germany, Biofund. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrow
Partner Germany, Growth Opportunities
Kurma Partners
The official roster identifies Daniel Parera as Partner Germany, Growth Opportunities. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authorit
Partner, Diagnostics
Kurma Partners
The official roster identifies Philippe Peltier as Partner, Diagnostics. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrowe
Partner, Growth Opportunities
Kurma Partners
The official roster identifies Jean-François Rivassou as Partner, Growth Opportunities. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authori
Partner, Biofund
Kurma Partners
The official roster identifies Hadrien Bouchez as Partner, Biofund. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrower ind
Associate, Diagnostics
Kurma Partners
The official roster identifies Laura Achach as Associate, Diagnostics. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrower
Associate, Diagnostics
Kurma Partners
The official roster identifies Samantha Zennou as Associate, Diagnostics. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrow
Associate, Biofund
Kurma Partners
The official roster identifies Florence de Coorebyter as Associate, Biofund. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a nar
Associate, Biofund
Kurma Partners
The official roster identifies Anna Tchorzewska as Associate, Biofund. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrower
Associate, Growth Opportunities
Kurma Partners
The official roster identifies Maylis Deschamps as Associate, Growth Opportunities. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority o
Analyst, Diagnostics
Kurma Partners
The official roster identifies Louise-Marie Rakotoarison as Analyst, Diagnostics. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or
Secretary General, Head of Compliance & Legal
Kurma Partners
The official roster identifies Muriel Domine as Secretary General, Head of Compliance & Legal. This is a fund team or operating role; no direct investment mandate or personal signing authority is infe
Financial Director
Kurma Partners
The official roster identifies Cyril Bedran as Financial Director. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Senior Financial Controller
Kurma Partners
The official roster identifies Sonny Guilhem as Senior Financial Controller. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Financial Controller
Kurma Partners
The official roster identifies Ornella Gomis as Financial Controller. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Office Manager
Kurma Partners
The official roster identifies Steffi Minga as Office Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Management Assistant
Kurma Partners
The official roster identifies Fatima Boubnad as Management Assistant. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Founder and Managing Partner
Panakès Partners
Fabrizio Landi works on Panakès Partners's strategy to back ambitious early-stage life-sciences teams developing products that address important medical needs and improve patient and caregiver outcome
Founder and Managing Partner
Panakès Partners
Alessio Beverina works on Panakès Partners's strategy to back ambitious early-stage life-sciences teams developing products that address important medical needs and improve patient and caregiver outco
Founder and Managing Partner
Panakès Partners
Diana Saraceni works on Panakès Partners's strategy to back ambitious early-stage life-sciences teams developing products that address important medical needs and improve patient and caregiver outcome
Partner
Panakès Partners
Barbara Castellano works on Panakès Partners's strategy to back ambitious early-stage life-sciences teams developing products that address important medical needs and improve patient and caregiver out
Partner
Panakès Partners
Rob Woodman works on Panakès Partners's strategy to back ambitious early-stage life-sciences teams developing products that address important medical needs and improve patient and caregiver outcomes.
Scientific Partner
Panakès Partners
Marco Sardina works on Panakès Partners's strategy to back ambitious early-stage life-sciences teams developing products that address important medical needs and improve patient and caregiver outcomes
Principal
Panakès Partners
Alessio Piuma works on Panakès Partners's strategy to back ambitious early-stage life-sciences teams developing products that address important medical needs and improve patient and caregiver outcomes
Investment Manager
Panakès Partners
Andrea Ballerini works on Panakès Partners's strategy to back ambitious early-stage life-sciences teams developing products that address important medical needs and improve patient and caregiver outco
Investment Manager
Panakès Partners
Giacomo Piccinini works on Panakès Partners's strategy to back ambitious early-stage life-sciences teams developing products that address important medical needs and improve patient and caregiver outc
Senior Analyst
Panakès Partners
Annalisa Coraducci works on Panakès Partners's strategy to back ambitious early-stage life-sciences teams developing products that address important medical needs and improve patient and caregiver out
Chief Financial Officer
Panakès Partners
Lorenzo Giordano serves Panakès Partners as Chief Financial Officer. The official sources do not publish a separate personal investment thesis, so the profile retains the firm's stated strategy withou
Office and Deal Flow Manager
Panakès Partners
Paola Crovato serves Panakès Partners as Office and Deal Flow Manager. The official sources do not publish a separate personal investment thesis, so the profile retains the firm's stated strategy with
Financial Controller and ESG Manager
Panakès Partners
Federica Porcu serves Panakès Partners as Financial Controller and ESG Manager. The official sources do not publish a separate personal investment thesis, so the profile retains the firm's stated stra
Network and Portfolio Talent Advisor
Panakès Partners
Michela Barcella serves Panakès Partners as Network and Portfolio Talent Advisor. The official sources do not publish a separate personal investment thesis, so the profile retains the firm's stated st
Founding Partner
i&i Bio
Karel Kubias, MBA invests or supports investment decisions through i&i Bio's published strategy: Invest in scientifically strong early-stage life-science companies, with primary focus on Central and E
Founding Partner
i&i Bio
Ivan Vohlmuth invests or supports investment decisions through i&i Bio's published strategy: Invest in scientifically strong early-stage life-science companies, with primary focus on Central and Easte
Partner
i&i Bio
Barbora Šumová, Ph.D. invests or supports investment decisions through i&i Bio's published strategy: Invest in scientifically strong early-stage life-science companies, with primary focus on Central a
Founding Partner
i&i Bio
Tomáš Maršálek, MBA invests or supports investment decisions through i&i Bio's published strategy: Invest in scientifically strong early-stage life-science companies, with primary focus on Central and
Partner
i&i Bio
Dr. Anela Vukoja invests or supports investment decisions through i&i Bio's published strategy: Invest in scientifically strong early-stage life-science companies, with primary focus on Central and Ea
Advisor
i&i Bio
Magdalena Marciniak, Ph.D. is listed in a Advisor capacity at i&i Bio. The firm does not publish a person-specific investment mandate for this role; the firm's strategy is included only as shared orga
Associate
i&i Bio
Pavlína Koutecká invests or supports investment decisions through i&i Bio's published strategy: Invest in scientifically strong early-stage life-science companies, with primary focus on Central and Ea
Office Manager
i&i Bio
Simona Šandová is listed in a Office Manager capacity at i&i Bio. The firm does not publish a person-specific investment mandate for this role; the firm's strategy is included only as shared organizat
Managing Partner
Vesalius Biocapital
Gaston Matthyssens, PhD invests or supports investments through Vesalius Biocapital's published strategy: Build a concentrated European life-sciences portfolio across therapeutics, diagnostics, medica
Managing Partner
Vesalius Biocapital
Alain Parthoens invests or supports investments through Vesalius Biocapital's published strategy: Build a concentrated European life-sciences portfolio across therapeutics, diagnostics, medical device
Managing Partner
Vesalius Biocapital
Christian Schneider, PhD invests or supports investments through Vesalius Biocapital's published strategy: Build a concentrated European life-sciences portfolio across therapeutics, diagnostics, medic
Managing Partner
Vesalius Biocapital
Stephane Verdood invests or supports investments through Vesalius Biocapital's published strategy: Build a concentrated European life-sciences portfolio across therapeutics, diagnostics, medical devic
Partner
Vesalius Biocapital
Guy Geldhof invests or supports investments through Vesalius Biocapital's published strategy: Build a concentrated European life-sciences portfolio across therapeutics, diagnostics, medical devices an
Managing Partner
Wellington Partners
Dr. Rainer Strohmenger invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics
Managing Partner
Wellington Partners
Dr. Johannes Fischer invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics,
Partner
Wellington Partners
Dr. Varun Gupta invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, medic
Managing Partner, CFO
Wellington Partners
Harald Keller is listed in a Managing Partner, CFO capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinct
Managing Partner, Legal Counsel
Wellington Partners
Ernst Mannheimer is listed in a Managing Partner, Legal Counsel capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the
Partner
Wellington Partners
Sabine Kannegiesser invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, m
Manager
Wellington Partners
Dr. Lisa Gartenmann invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, m
Associate
Wellington Partners
Dr. Robert Buschauer invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics,
Office Manager
Wellington Partners
Karina Schuster is listed in a Office Manager capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction a
Sustainability Manager
Wellington Partners
Ulrike Spring is listed in a Sustainability Manager capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinc
Finance Manager
Wellington Partners
Cornelia Huber is listed in a Finance Manager capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction a
Finance Manager
Wellington Partners
Karin Juen is listed in a Finance Manager capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and u
Finance Manager
Wellington Partners
Anja Weibel is listed in a Finance Manager capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and
Finance Manager
Wellington Partners
Olena Ionkina is listed in a Finance Manager capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction an
Project Manager
Wellington Partners
Doris Gowik invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, medical d
Venture Advisor
Wellington Partners
Dr. Regina Hodits is listed in a Venture Advisor capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinctio
Venture Partner
Wellington Partners
Prof. Dr. Erich Schlick invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutic
Venture Partner
Wellington Partners
Dr. Ulrich Granzer invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, me
Venture Partner
Wellington Partners
Dr. Mel Spigelman invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, med
Venture Partner
Wellington Partners
Dr. Wolfgang Baiker invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, m
Venture Partner
Wellington Partners
Stuart Essig, Ph.D. invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, m
Venture Partner
Wellington Partners
Dr. Bo Jesper Hansen invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics,
Venture Partner
Wellington Partners
Dr. Peter Hirth invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, medic
Chief Executive Officer
Newton Biocapital
Alain Parthoens is listed in a Chief Executive Officer capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distin
Japan Representative
Newton Biocapital
Sadashi Suzuki is listed in a Japan Representative capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinctio
Chief Medical and Regulatory Officer
Newton Biocapital
Guy Heynen is listed in a Chief Medical and Regulatory Officer capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves the rol
Chief Regulatory and Development Officer
Newton Biocapital
Michihiko Wada is listed in a Chief Regulatory and Development Officer capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves
Chief Operating Officer
Newton Biocapital
Danny Gonnissen is listed in a Chief Operating Officer capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distin
Venture Director
Newton Biocapital
Pierre Detrixhe invests or supports investments through Newton Biocapital's published strategy: Invest in private life-sciences companies in Europe and Japan whose products address important unmet med
Partner
Newton Biocapital
Tomoko Asaoka invests or supports investments through Newton Biocapital's published strategy: Invest in private life-sciences companies in Europe and Japan whose products address important unmet medic
Chief Financial Officer
Newton Biocapital
Dario Padovani is listed in a Chief Financial Officer capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinc
Venture Partner
Newton Biocapital
Daisuke Morishita invests or supports investments through Newton Biocapital's published strategy: Invest in private life-sciences companies in Europe and Japan whose products address important unmet m
Assistant to the CEO / Office Manager
Newton Biocapital
Toko Senna is listed in a Assistant to the CEO / Office Manager capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves the ro
Chairman of the Board of NBC I and NBC II
Newton Biocapital
Ajit Shetty is listed in a Chairman of the Board of NBC I and NBC II capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves t
Vice-Chairman and Chairman of the Audit Committee of NBC I and NBC II
Newton Biocapital
Dirk Boogmans is listed in a Vice-Chairman and Chairman of the Audit Committee of NBC I and NBC II capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this
Independent Director
Newton Biocapital
Jean Combalbert is listed in a Independent Director capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distincti
Chairman Emeritus and Advisor to the Board of NBC I and NBC II
Newton Biocapital
Jean-Claude Deschamps is listed in a Chairman Emeritus and Advisor to the Board of NBC I and NBC II capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for thi
Founder
Newton Biocapital
Goro Takeda is listed in a Founder capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the f
Founder & CEO
NLC Health Ventures
Bert-Arjan Millenaar is listed in a Founder & CEO capacity at NLC Health Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distincti
CFO
NLC Health Ventures
Ruben Mikkers is listed in a CFO capacity at NLC Health Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the f
Head of Legal, Company Secretary
NLC Health Ventures
Amalia Stenberg is listed in a Head of Legal, Company Secretary capacity at NLC Health Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves the
Head of Investor Relations & Business Development
NLC Health Ventures
Emke Bus is listed in a Head of Investor Relations & Business Development capacity at NLC Health Ventures. The firm does not publish a person-specific investment thesis for this role; the profile pres
Venture Partner, Orthopedics, Spine & Surgery
NLC Health Ventures
Ileana Lindeman invests or supports investments through NLC Health Ventures's published strategy: Find, build and scale health innovations from universities, hospitals and corporates, investing alongs
Venture Partner, Therapeutics
NLC Health Ventures
Ian Metcalfe invests or supports investments through NLC Health Ventures's published strategy: Find, build and scale health innovations from universities, hospitals and corporates, investing alongside
Entrepreneur in Residence
NLC Health Ventures
Nia Emami-Shahri, PhD is listed in a Entrepreneur in Residence capacity at NLC Health Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves the r
Cluster Talent Partner & Recruiter
NLC Health Ventures
Augusta Poteliunaite is listed in a Cluster Talent Partner & Recruiter capacity at NLC Health Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserv
Legal Counsel
NLC Health Ventures
Carlos Garcia Tognaccini is listed in a Legal Counsel capacity at NLC Health Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role disti